What the future may hold for four big company names looking to become big names in healthcare.

Partner, Health & Life Sciences, Oliver Wyman

Asian healthcare is undergoing major disruption, and a new healthcare environment is emerging.

Partner, Head of Health & Life Sciences, Asia Pacific, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

There's big buzz around consumer behavior driving outcomes. But clinical data doesn't yet align with behavioral data.

Principal, Health & Life Sciences, Oliver Wyman

Healthcare companies should look to rebuild trust by doubling down on employee communications and fostering engagements that are driven by employees themselves.

Global Chair, Health, Edelman

Diversity as a Strategic Priority

How can your I&D goals thrive? Walk the talk, says Florida Blue's CEO.

President and CEO, Florida Blue
CEO, Health Evolution
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

Insights in your inbox

Subscribe

At HES, discussion around long-term "impact" was everywhere. Let's get moving.

Partner, Health & Life Sciences, Oliver Wyman

Consumers conduct hundreds of millions of health-related Google searches daily. In the meantime, Google’s industry impact is taking shape.

Predictions on the next wave of innovation, what consumers really want, and how it's all impacting employer benefits.

They Just Have to Persuade People to Like Them

Oliver Wyman research examines whether consumers are using healthcare’s “new front door”, and if not, why not.

Principal, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Here’s how organizations like Zipongo, ProMedica, and Walmart are strategizing around the food as medicine movement.

Partner, Health & Life Sciences, Oliver Wyman
Vice President, Health Transformation, Walmart
President & CEO, ProMedica
Founder and CEO

Insights in your inbox

Subscribe
Load More